AGO4

AGO4 is an Argonaute-family protein whose functions diverge sharply between the human and plant orthologs. Human AGO4 is catalytically inactive, its slicer function abolished by defects in the catalytic center, short N-terminal sequence elements, and an AGO4-specific insertion in the catalytic domain, as demonstrated by AGO2-AGO4 chimera cleavage assays (PMID:25114291). In the male germline, human/mouse AGO4 localizes to spermatocyte nuclei during meiotic prophase I, concentrating at sites of asynapsis and the XY sex body, where it is required for meiotic sex chromosome inactivation and for restraining premature meiotic entry; its loss causes early induction of retinoic-acid-response genes and dramatic loss of X-chromosome-encoded microRNAs (PMID:22863743). AGO4 acts together with AGO3 in this process, and the two displace the BAF-complex remodeler BRG1 from XY chromatin to enforce transcriptional silencing and correct timing of spermiogenic gene expression [PMID:bio_10.1101_2024.12.31.630913]. Beyond RNA-related roles, human AGO4 also participates in a non-miRNA pathway in which it interacts with the E3 ligase TRIM21 and the chaperone GRP78, stabilizing TRIM21 and promoting K48-linked polyubiquitination and degradation of GRP78, thereby inducing apoptosis and inhibiting autophagy via mTOR activation in NSCLC cells (PMID:36371565). In contrast, the plant ortholog AGO4 is a catalytically active slicer that loads 24-nt siRNA duplexes, cleaves the passenger strand, slices and retains target RNAs, and thereby directs de novo cytosine methylation at RdDM loci (PMID:36746605).

1. 2012 High

   Establishing AGO4's in vivo role addressed whether an Argonaute protein functions in the male meiotic program, revealing its requirement for sex chromosome inactivation and meiotic timing.

   Evidence Ago4 knockout mouse with immunofluorescence localization, meiotic staging, and microRNA profiling

   PMID:22863743

   Open questions at the time

   • Did not define the molecular mechanism by which AGO4 enforces MSCI
   • Causal link between microRNA loss and silencing defects not established
   • Did not determine whether AGO4 acts catalytically or as a scaffold in this context
2. 2014 High

   Resolving whether human AGO4 can cleave RNA answered a basic biochemical question, showing it is catalytically dead due to specific structural lesions rather than a single point defect.

   Evidence In vitro cleavage assay with AGO2-AGO4 chimeras and domain-swap mutagenesis

   PMID:25114291

   Open questions at the time

   • Did not address what slicer-independent activity AGO4 retains in cells
   • Functional consequence of catalytic inactivation for germline roles unexplored
3. 2022 Medium

   Identifying a non-miRNA function addressed whether AGO4 has roles outside RNA silencing, implicating it in ubiquitin-mediated control of a chaperone with apoptotic and autophagic consequences.

   Evidence Co-immunoprecipitation, ubiquitination assays, and overexpression/knockdown in NSCLC cell lines and xenograft models

   PMID:36371565

   Open questions at the time

   • Single lab without reciprocal validation of the TRIM21-AGO4-GRP78 axis
   • Direct versus indirect role of AGO4 in promoting ubiquitination unresolved
   • Generality beyond NSCLC not tested
4. 2023 High

   Reconstituting plant AGO4 enzymology answered how the ortholog directs DNA methylation, defining it as an active slicer that loads siRNA duplexes, cleaves passenger and target strands, and retains products to drive RdDM.

   Evidence In vitro slicing assays with recombinant AGO4 and synthetic RNAs plus slicing-competent vs slicing-defective transgenic plants with methylation profiling

   PMID:36746605

   Open questions at the time

   • Plant-specific; does not bear on human AGO4 mechanism
   • How sliced-product retention is mechanistically coupled to methylation machinery not fully resolved
5. 2025 Medium

   Distinguishing AGO4's silencing mechanism addressed how it achieves MSCI, showing AGO3/AGO4 displace the remodeler BRG1 from XY chromatin to enforce silencing and proper germline gene timing.

   Evidence Ago4/Ago3 double-knockout mouse with immunofluorescence, AGO3-BRG1 co-immunoprecipitation, and transcriptional profiling (preprint)

   PMID:bio_10.1101_2024.12.31.630913

   Open questions at the time

   • Preprint, single lab, not yet peer-reviewed
   • Direct AGO4-BRG1 interaction not demonstrated (Co-IP shown for AGO3)
   • Mechanism linking AGO4 RNA binding to BRG1 displacement unresolved

• How human AGO4's catalytic inactivation, germline chromatin role, and ubiquitin-pathway function are mechanistically connected — and whether they reflect distinct molecular activities — remains unresolved.
• No unifying model linking AGO4's silencing and ubiquitination roles
• Recruitment mechanism of AGO4 to XY chromatin not defined
• Whether RNA binding is required for the TRIM21/GRP78 pathway is unknown